News

Lecture on July 11, 2024 - Dr Koola, Maju M. Lecture on July 11, 2024 - Dr Koola, Maju M. We are pleased to invite you to an lecture titled "KYNA-NMDA-α7nAChR Centric Pathophysiology: Is This What We Have Been Waiting for?" to be delivered by Dr Koola, Maju M. The lecture will take place in the conference hall on July 11, 2024, at 2:00 PM.
New Impact Factor of New Impact Factor of According to the latest "Journal Citation Reports" list, published on 20 June 2024, "Pharmacological Reports" obtained an Impact Factor of 3.6 (five-year Impact Factor = 3.2). The journal was ranked in the second quartile (Q2) in the field "PHARMACOLOGY & PHARMACY". Despite the decrease in the Impact Factor value compared to last year, which reflects the downward trend recorded in the case of most journals (the effect of changes in the citation rules introduced by Clarivate and less frequently cited articles on COVID-19), "Pharmacological Reports" improved its position among journals in this scientific category - 73.6 percentile - the highest position recorded in the history of the journal. We would like to thank the Editorial Team, Associate Editors, Reviewers and Authors for their cooperation, and efforts to ensure the high quality of the journal and for contributing to its constant development. Readers and potential Authors are invited to submit articles for publication, as well as to submit topics and collaborate on special issues of the journal.
Open lecture on March 27, 2024 - Prof. Emanuele Amata Ph.D Open lecture on March 27, 2024 - Prof. Emanuele Amata Ph.D We are honored to invite you to an open lecture scheduled to take place in the conference hall of IF PAN at 11 a.m. on the 27th of March, 2024. The lecture, entitled: Development of Sigma Receptor modulator as non-opioid/non-narcotic agents for the treatment of Neuropathic Pain, will be delivered by Prof. Emanuele Amata Ph.D. from the University of Catania. 
"ROS-Scavenging Magnetic Nanozymes with Remote Activation for Alzheimer Disease" (ROSSCA) as part of the M-ERA.NET Call 2023 competition, in the "Advanced materials and technologies for health applications" "ROS-Scavenging Magnetic Nanozymes with Remote Activation for Alzheimer Disease" (ROSSCA) as part of the M-ERA.NET Call 2023 competition, in the "Advanced materials and technologies for health applications" We are pleased to announce that the project is implemented by an international consortium composed of 4 partners with skills and experience in the field of physics and materials science, genetic toxicology, molecular biology and neuropsychopharmacology. Ph.D. Anna Haduch, as the task manager, received funding for an international project entitled "ROS-Scavenging Magnetic Nanozymes with Remote Activation for Alzheimer Disease" (ROSSCA) as part of the M-ERA.NET Call 2023 competition, in the "Advanced materials and technologies for health applications" category. The competition was organized by the M-ERA.NET 3 network, which supports international research projects in materials science and engineering.